Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
JAGXthis companyJaguar Health, Inc.	$0.43	-0.04×	-0.13×	0.19×	-0.87×	-57343234.5%	67.2%	-391.9%	-464.2%	309.1%	-178.3%	-1091.7%	-2.52×	-0.82×	673.25×	0.5×	0.0%	3	-20.04	2	C
CLDICalidi Biotherapeutics, Inc.	$0.73	-0.2×	1.34×	0×	-0.11×	1110.0%	0.0%	0.0%	0.0%	-529.6%	-314.4%	-425.4%	0.68×	0.17×	-97.78×	1.59×	0.0%	1	-36.44	2	C+
CNSPCNS Pharmaceuticals, Inc.	$3.92	-0.15×	0.51×	0×	0.29×	87.5%	0.0%	0.0%	0.0%	-350.5%	-329.5%	-594.1%	0.07×	0.43×	-1,049.68×	1.98×	0.0%	1	-7.47	2	C+
GNPXGenprex, Inc.	$2.09	-0.1×	0.21×	0×	0.4×	8100.2%	0.0%	0.0%	0.0%	-203.8%	-194.3%	-938.0%	0×	0.51×	-20.97×	3.84×	0.0%	2	-16.52	2	B-
GRIGRI Bio, Inc.	$1.84	-0.06×	0.11×	0×	0.62×	3375.5%	0.0%	0.0%	0.0%	-199.0%	-197.0%	-1502.1%	0.01×	0.68×	0×	3.25×	0.0%	1	-6.5	3	B
SILOSilo Pharma, Inc.	$1.61	-0.68×	0.45×	39.53×	0.45×	308.0%	-1128.9%	-5937.0%	-5863.5%	-67.0%	-61.5%	-163.6%	0×	1.14×	-114.76×	11.36×	0.0%	1	-5.92	2	C+
Peer median	—	-0.15×	0.45×	0×	0.4×	1110.0%	0.0%	0.0%	0.0%	-203.8%	-197.0%	-594.1%	0.01×	0.51×	-97.78×	3.25×	0.0%	1	-7.47	2	—